149 related articles for article (PubMed ID: 9299594)
1. Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells.
Elstein KH; Mole ML; Setzer RW; Zucker RM; Kavlock RJ; Rogers JM; Lau C
Toxicol Appl Pharmacol; 1997 Sep; 146(1):29-39. PubMed ID: 9299594
[TBL] [Abstract][Full Text] [Related]
2. Utility of the murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: application to 5-fluorouracil.
Elstein KH; Zucker RM; Shuey DL; Lau C; Chernoff N; Rogers JM
Teratology; 1993 Jul; 48(1):75-87. PubMed ID: 7688913
[TBL] [Abstract][Full Text] [Related]
3. Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat.
Shuey DL; Lau C; Logsdon TR; Zucker RM; Elstein KH; Narotsky MG; Setzer RW; Kavlock RJ; Rogers JM
Toxicol Appl Pharmacol; 1994 May; 126(1):129-44. PubMed ID: 8184423
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-fluorouracil on embryonic rat palate in vitro: fusion in the absence of proliferation.
Abbott BD; Lau C; Buckalew AR; Logsdon TR; Setzer W; Zucker RM; Elstein KH; Kavlock RJ
Teratology; 1993 Jun; 47(6):541-54. PubMed ID: 8367827
[TBL] [Abstract][Full Text] [Related]
5. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data.
Lau C; Mole ML; Copeland MF; Rogers JM; Kavlock RJ; Shuey DL; Cameron AM; Ellis DH; Logsdon TR; Merriman J; Setzer RW
Toxicol Sci; 2001 Jan; 59(1):37-48. PubMed ID: 11134542
[TBL] [Abstract][Full Text] [Related]
6. Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.
Houghton JA; Tillman DM; Harwood FG
Clin Cancer Res; 1995 Jul; 1(7):723-30. PubMed ID: 9816038
[TBL] [Abstract][Full Text] [Related]
7. Biological modeling of 5-fluorouracil developmental toxicity.
Shuey DL; Setzer RW; Lau C; Zucker RM; Elstein KH; Narotsky MG; Kavlock RJ; Rogers JM
Toxicology; 1995 Sep; 102(1-2):207-13. PubMed ID: 7482555
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.
Pressacco J; Wiley JS; Jamieson GP; Erlichman C; Hedley DW
Br J Cancer; 1995 Oct; 72(4):939-42. PubMed ID: 7547244
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
Eriksson S; Skog S; Tribukait B; Wallström B
Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.
Banti S; Miller PJ; Parker CD; Ananth SL; Horn LL; Babu YS; Sandhu JS
Int Immunopharmacol; 2002 Jun; 2(7):913-23. PubMed ID: 12188033
[TBL] [Abstract][Full Text] [Related]
11. Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations.
Elstein KH; Zucker RM; Andrews JE; Ebron-McCoy M; Shuey DL; Rogers JM
Teratology; 1993 Oct; 48(4):355-63. PubMed ID: 8278935
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization.
Hwang HS; Davis TW; Houghton JA; Kinsella TJ
Cancer Res; 2000 Jan; 60(1):92-100. PubMed ID: 10646859
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
Kinahan JJ; Otten M; Grindey GB
Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
[TBL] [Abstract][Full Text] [Related]
14. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues.
Shuey DL; Buckalew AR; Wilke TS; Rogers JM; Abbott BD
Teratology; 1994 Dec; 50(6):379-86. PubMed ID: 7778042
[TBL] [Abstract][Full Text] [Related]
15. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: a mathematical construct.
Setzer RW; Lau C; Mole ML; Copeland MF; Rogers JM; Kavlock RJ
Toxicol Sci; 2001 Jan; 59(1):49-58. PubMed ID: 11134543
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic efficacy of 5-fluorouracil with concurrent thymidine infusion against transplantable colon tumors in rodents.
Danhauser LL; Rustum YM
Cancer Drug Deliv; 1984; 1(4):269-82. PubMed ID: 6549560
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of mutations in the hprt gene of V79 hamster fibroblasts: effects of imbalances in the dCTP, dGTP and dTTP pools.
Darè E; Zhang LH; Jenssen D; Bianchi V
J Mol Biol; 1995 Oct; 252(5):514-21. PubMed ID: 7563070
[TBL] [Abstract][Full Text] [Related]
18. Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
Fried J; Perez AG; Doblin JM; Clarkson BD
Cell Tissue Kinet; 1983 Nov; 16(6):539-48. PubMed ID: 6627345
[TBL] [Abstract][Full Text] [Related]
19. Deoxyribonucleoside triphosphates in human cells: changes in disease and following exposure to drugs.
Tattersall MH; Lavoie A; Ganeshaguru K; Tripp E; Hoffbrand AV
Eur J Clin Invest; 1975 Apr; 5(2):191-202. PubMed ID: 1149780
[TBL] [Abstract][Full Text] [Related]
20. Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
Leyva A; Appel H; Pinedo HM
Cancer Biochem Biophys; 1984 Sep; 7(3):231-7. PubMed ID: 6333268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
